Table 6.
Evaluable patients’ characteristics
| All | Random |
P value | |||
|---|---|---|---|---|---|
| A | B | ||||
| Patients, n | 113 | 59 | 54 | ||
| Sex | Male | 43 (38%) | 22 (37.3%) | 21 (38.9%) | .8610 |
| Female | 70 (62%) | 37 (62.7%) | 33 (61.1%) | ||
| Age, y | Median (range) | 45 (18.2-79.6) | 42.5 (18.2-79.6) | 48.2 (21.5-78.7) | .0944 |
| Platelet count | Median (range) | 8.5 × 109/L (1-48) | 9.0 × 109/L (1-48) | 8.0 × 109/L (1-27) | .9119 |
| Bleeding score (available in 95 patients) | 0-4 | 76 (80.0%) | 40 (80.0%) | 36 (80.0%) | 1.0000 |
| 5-9 | 14 (14.7%) | 7 (14.0%) | 7 (15.6%) | ||
| 10-15 | 5 (5.3%) | 3 (6.0%) | 2 (4.4%) | ||
| Bleeding site (available in 84 patients) | Cutaneous bleeding | 64 (76.2) | 33 (75.0%) | 31 (77.5%) | .8681 |
| Mucosal bleeding | 15 (17.8) | 9 (20.4%) | 6 (15.0%) | ||
| Gastrointestinal∗ | 2 (2.4) | 1 (2.3%) | 1 (2.5%) | ||
| Genitourinary tract bleeding | 2 (2.4) | 1 (2.3%) | 1 (2.5%) | ||
| Urinary bleeding | 1 (1.2) | 0 (0.0%) | 1 (2.5%) | ||
∗
Not due to active gastric ulcer.